Shaoxing Yang

432 total citations
21 papers, 294 citations indexed

About

Shaoxing Yang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shaoxing Yang has authored 21 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shaoxing Yang's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (5 papers) and Management of metastatic bone disease (5 papers). Shaoxing Yang is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (5 papers) and Management of metastatic bone disease (5 papers). Shaoxing Yang collaborates with scholars based in China and United States. Shaoxing Yang's co-authors include Hongjun Gao, Haifeng Qin, Yaosheng Liu, Mingxing Lei, Wenjing Liu, Chuanhao Tang, Weixia Wang, Xiaoqing Liu, Panpan Lv and Hao Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Oncotarget.

In The Last Decade

Shaoxing Yang

21 papers receiving 293 citations

Peers

Shaoxing Yang
Hajime Shibuya Japan
Maria Aurelia Barbera Italy
Hao Dang Netherlands
Juan Ruiz‐Bañobre Spain
Yiran Cai China
Oldřich Coufal Czechia
Kiruthikah Thillai United Kingdom
Qiaoqi Sui China
S.-H.I. Ou United States
Delphine Daydé France
Hajime Shibuya Japan
Shaoxing Yang
Citations per year, relative to Shaoxing Yang Shaoxing Yang (= 1×) peers Hajime Shibuya

Countries citing papers authored by Shaoxing Yang

Since Specialization
Citations

This map shows the geographic impact of Shaoxing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoxing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoxing Yang more than expected).

Fields of papers citing papers by Shaoxing Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoxing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoxing Yang. The network helps show where Shaoxing Yang may publish in the future.

Co-authorship network of co-authors of Shaoxing Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoxing Yang. A scholar is included among the top collaborators of Shaoxing Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoxing Yang. Shaoxing Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jing, Hongjun Gao, Shaoxing Yang, et al.. (2023). Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. Thoracic Cancer. 14(20). 1980–1990. 2 indexed citations
2.
Yang, Shaoxing, Jing Xu, Panpan Lv, et al.. (2022). Efficacy of different sequential patterns after crizotinib progression in advanced anaplastic lymphoma kinase‐positive non–small cell lung cancer. Thoracic Cancer. 13(12). 1788–1794. 3 indexed citations
3.
Zhang, Kun, Hongjun Gao, Hong Wang, et al.. (2020). <p>Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study</p>. Cancer Management and Research. Volume 12. 3409–3417. 33 indexed citations
4.
5.
Lv, Panpan, Shaoxing Yang, Wenjing Liu, et al.. (2019). Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor‐tyrosine kinase inhibitor therapy. Thoracic Cancer. 11(1). 29–40. 19 indexed citations
6.
7.
Lv, Panpan, Liu Ze-yuan, Bin Xu, et al.. (2019). Exploratory study on application of MALDI‑TOF‑MS to detect serum and urine peptides related to small cell lung carcinoma. Molecular Medicine Reports. 21(1). 51–60. 6 indexed citations
8.
Zhao, Guanhua, Bin Xu, Xiaoyan Li, et al.. (2017). [Detection of Serum Peptides in Patients with Lung Squamous Cell Carcinoma by MALDI-TOF-MS and Analysis of Their Correlation with Chemotherapy Efficacy].. SHILAP Revista de lepidopterología. 20(5). 318–325. 1 indexed citations
9.
Li, Liangliang, Lili Qu, Hanjiang Fu, et al.. (2017). Circulating microRNAs as novel biomarkers of ALK-positive non-small cell lung cancer and predictors of response to crizotinib therapy. Oncotarget. 8(28). 45399–45414. 23 indexed citations
10.
Gao, Hongjun, Wenjing Liu, Shaoxing Yang, et al.. (2017). Detection of circulating tumor cells using oHSV1‐hTERT‐GFP in lung cancer. Thoracic Cancer. 9(1). 44–50. 5 indexed citations
11.
12.
13.
Yang, Shaoxing, Fei Qi, Chuanhao Tang, et al.. (2016). CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells. Oncology Letters. 13(2). 898–904. 14 indexed citations
14.
Lei, Mingxing, et al.. (2016). Percutaneous cementoplasty for painful osteolytic distal femur metastases: a case report. Journal of Pain Research. Volume 9. 859–863. 4 indexed citations
15.
Chen, Baoan, Runzhe Chen, Shaoxing Yang, et al.. (2016). Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo. OncoTargets and Therapy. Volume 9. 4215–4224. 17 indexed citations
16.
17.
Yang, Shaoxing, Jian Cui, Zhaoping Liu, et al.. (2015). Over-expressed RPL34 promotes malignant proliferation of non-small cell lung cancer cells. Gene. 576(1). 421–428. 37 indexed citations
18.
19.
Tang, Chuanhao, Hongjun Gao, Xiaoyan Li, et al.. (2014). Different treatment orders achieved similar clinical results: a retrospective study for retreatment of epidermal growth factor receptor tyrosine kinase inhibitors in 120 patients with non-small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. 140(3). 427–433. 9 indexed citations
20.
Yang, Shaoxing, Chuanhao Tang, Sihan Wang, Santai Song, & Xiaoqing Liu. (2012). [Construction of a CD147 lentiviral expression vector and establishment of its stably transfected A549 cell line].. SHILAP Revista de lepidopterología. 15(12). 694–700. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hajime Shibuya Breakdown of academic impact, for papers by Maria Aurelia Barbera Breakdown of academic impact, for papers by Hao Dang Breakdown of academic impact, for papers by Juan Ruiz‐Bañobre Breakdown of academic impact, for papers by Yiran Cai Breakdown of academic impact, for papers by Oldřich Coufal Breakdown of academic impact, for papers by Kiruthikah Thillai Breakdown of academic impact, for papers by Qiaoqi Sui Breakdown of academic impact, for papers by S.-H.I. Ou Breakdown of academic impact, for papers by Delphine Daydé
Rankless by CCL
2026